0001683168-20-001968.txt : 20200616
0001683168-20-001968.hdr.sgml : 20200616
20200616172335
ACCESSION NUMBER: 0001683168-20-001968
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200612
FILED AS OF DATE: 20200616
DATE AS OF CHANGE: 20200616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Keyes Jeffry R.
CENTRAL INDEX KEY: 0001557736
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39126
FILM NUMBER: 20967358
MAIL ADDRESS:
STREET 1: 13950 STOWE DRIVE
CITY: POWAY
STATE: CA
ZIP: 92064-8803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001729427
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822318545
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
BUSINESS PHONE: 1-800-946-9185 X701
MAIL ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
4
1
ownership.xml
X0306
4
2020-06-12
0
0001729427
CNS Pharmaceuticals, Inc.
CNSP
0001557736
Keyes Jeffry R.
C/O CNS PHARMACEUTICALS, INC.
100 WEST LOOP SOUTH, SUITE 900
HOUSTON
TX
77027
1
0
0
0
Option to purchase common stock
2.47
2020-06-12
4
A
0
46559
A
2030-06-12
Common Stock
46559
146559
D
The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date.
The stock options were issued in connection with the reporting person's Board of Director services to the Company.
/s/ Christopher Downs, Attorney-in-fact
2020-06-16